Google AI outperforms general pathologists at validating Gleason grading of prostate cancer biopsies
A team of researchers from Google Health, working with others from institutions across the U.S. and Canada has found that a Google AI system was able to outperform general pathologists when validating ...
The prevalence of objectively measurable disease in phase III trials of metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the 2016 Genitourinary Cancers ...
Prospective evaluation of neuromediators during treatment with docetaxel in castration resistant prostate cancer. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results